There was evidence of increased risk of the primary outcome (a composite of death, myocardial infarction and hospitalization for heart failure or stroke) in the high-Hb compared with the low-Hb group [hazard ratio (HR) 1.34 (95% CI 1.03, 1.74)]. This evidence concerns the gene GSTM1 and heart failure.